STEINMAN LAWRENCE bought KTTA
November 28, 2025 · Form 4 insider transaction
STEINMAN LAWRENCE bought 133,333 shares of Pasithea Therapeutics Corp. at $0.75 per share, a transaction worth $100.0K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
133,333
Price
$0.75
Total value
$100.0K
InsiderSTEINMAN LAWRENCE
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateNovember 28, 2025
Filing dateDecember 1, 2025
Shares owned after199,691
OwnershipDirect
10b5-1 planNo
AmendedNo